- What it is: A rare ANCA-associated vasculitis, an autoimmune inflammation of small blood vessels that can damage the kidneys, lungs, skin and nerves.
- Common symptoms: Fatigue, fever, weight loss, joint and muscle pain, rash, blood in the urine, cough or shortness of breath, and numbness or weakness in the hands and feet.
- Conventional care: Specialist-led immune-suppressing treatment, typically high-dose glucocorticoids with rituximab or cyclophosphamide, then maintenance therapy and long-term monitoring.
- How integrative care fits: Supportive care for fatigue, pain, sleep and stress once the disease is under medical treatment, with your treating team's knowledge.
- Evidence at a glance: None found for MPA itself. Evidence for related symptoms, such as in kidney disease, is low quality and may not apply.
What is Microscopic Polyangiitis?
Microscopic polyangiitis (MPA) is a necrotizing vasculitis, meaning inflammation that damages small blood vessels such as capillaries, venules and arterioles. It belongs to the group of ANCA-associated vasculitides, which also includes granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.[1, 2] It is a rare disease and among the most serious forms of autoimmune inflammation.[3]
Common symptoms
MPA often affects the kidneys, lungs, skin and peripheral nerves.[3] It commonly causes glomerulonephritis (inflammation of the kidney filters) and capillary inflammation in the lungs, and it is more likely than granulomatosis with polyangiitis to involve the kidneys.[1]
General symptoms such as fatigue, fever, weight loss and joint or muscle pain are common, along with rash, blood in the urine, cough or coughing up blood, and numbness or weakness in the hands and feet. Which symptoms appear depends on the organs involved.
Causes and risk factors
The cause is not fully understood. It is an autoimmune disease in which ANCA antibodies and activated white blood cells, with other immune events such as complement pathway activation, drive inflammation in small vessels.[3] Genetic susceptibility, infections and some medicines have been suggested as triggers.[1]
How it is diagnosed and treated conventionally
Diagnosis rests on symptoms, ANCA blood testing and biopsy of an affected organ.[1, 4] ANCA tests help but are neither necessary nor sufficient on their own for the diagnosis.[1]
Treatment is directed by specialists. For life-threatening or organ-threatening disease, the EULAR recommendations advise high-dose glucocorticoids with rituximab or cyclophosphamide, tapered over months, and rituximab for maintenance. Plasma exchange may be considered in rapidly progressive glomerulonephritis, and avacopan may reduce steroid exposure.[4] The British Society for Rheumatology also issued updated recommendations in 2025.[5]
Earlier diagnosis has improved survival, and attention has shifted to long-term problems such as chronic kidney disease, cardiovascular disease and the effects of glucocorticoids.[3]
Why Microscopic Polyangiitis calls for a whole-person approach
MPA is an organ-threatening disease, so the first priority is medical treatment that controls vessel inflammation. Alongside that, many people are left with fatigue, pain, poor sleep, nerve symptoms and the effects of long-term medication.
The points below describe areas where supportive care is sometimes considered. They have not been studied in MPA itself.
Treatment side effects
Reducing exposure to glucocorticoids is a main aim of current treatment, because long-term morbidity is partly due to treatment toxicity.[3, 4] Complementary care should not add to this burden or interfere with medicines.
Kidney health
The kidneys are the organ most often affected, and long-term kidney disease is a recognized outcome.[1, 3] This matters for herbs, since some herbal products can harm the kidneys.[6]
Fatigue and sleep
Fatigue is common in vasculitis and other chronic illnesses, and sleep problems add to it. Supportive approaches target these symptoms rather than the disease. In chronic kidney disease, a Cochrane review found very low quality evidence that acupressure reduced fatigue, depression and poor sleep in people on hemodialysis.[7]
Nerve symptoms and pain
Peripheral nerves are often affected, and numbness, tingling and pain can persist.[3] Nerve and joint pain are symptoms that supportive care may be asked to help with, but a physician needs to evaluate any new nerve symptom first.
Acupuncture as supportive care in Microscopic Polyangiitis
What the research shows
No clinical trials of acupuncture for MPA or other ANCA-associated vasculitis were found in PubMed. Acupuncture cannot be said to treat this disease or to affect the vessel inflammation.
Some research addresses symptoms in related settings. A Cochrane review of 24 studies in chronic kidney disease (1,787 participants) found very low quality evidence that manual acupressure helped fatigue, depression and sleep in people on hemodialysis. It found little evidence about other forms of acupuncture or about pain, and it could not judge safety because harms were poorly reported.[7] A meta-analysis of 24 trials in insomnia found acupuncture improved sleep scores compared with medication, mostly after about three weeks, with large differences between studies.[8] These results are for other populations and may not apply to people with MPA.
How acupuncture may work
There is no research on how acupuncture might act in vasculitis, so we cannot offer a mechanism for this disease.
What treatment involves
Sessions use fine, sterile, single-use needles, usually left in for about 20 to 40 minutes, with a short course of visits followed by reassessment.
In prospective studies, about 9 in 100 patients had a minor reaction such as soreness or bleeding at a needle site, and serious events occurred in about 1 in 10,000 patients.[9] Because MPA treatment lowers immune defenses, tell the practitioner first if you take glucocorticoids, rituximab, cyclophosphamide or other immunosuppressants, have skin ulcers or purpura, a low platelet count, a bleeding disorder, take blood thinners, are pregnant, or have a pacemaker (relevant to electroacupuncture).
Ayurvedic medicine as supportive care in Microscopic Polyangiitis
The Ayurvedic view
Ayurveda has no classical name for MPA. Inflammatory conditions of the blood vessels and skin are traditionally discussed in terms of Pitta and Rakta (blood) imbalance, and weakness or fatigue in terms of reduced strength (ojas). These are traditional frameworks, not medical diagnoses.
Therapies that may be used
Care is individual and, in this setting, would stay gentle: diet and daily routine advice, rest, stress-reduction practices such as breathing exercises, and mild oil massage if the skin is intact.
Panchakarma is not appropriate during pregnancy, acute illness or frailty. It is not suitable for MPA, because the disease is serious, treated with strong immune-suppressing drugs, and often involves the kidneys.
What the research shows
No studies of Ayurvedic treatment for MPA or other vasculitis were found, so the evidence is none. Ayurvedic herbs have not been tested in this disease.
Safety is a concern. One study found detectable lead, mercury or arsenic in about one fifth of Ayurvedic medicines bought online.[10] Heavy metals are harmful to the kidneys, a major concern in MPA. Ayurvedic herbs may also interact with prescribed medicines, as other herbs do.[11]
Herbal medicine as supportive care in Microscopic Polyangiitis
Herbs and formulas that have been studied
No herbs or formulas have been tested in MPA. Chinese herbs such as Astragalus (huang qi) have been studied in chronic kidney disease in general.[12]
What the research shows
A Cochrane review of 22 studies (1,323 people) of Astragalus in chronic kidney disease found possible reductions in protein in the urine and increases in hemoglobin and albumin, but the study quality was low and reporting was poor, so no firm conclusions could be drawn. Most trials did not report side effects.[12] These findings are for chronic kidney disease, not for MPA, and cannot be taken to show benefit in vasculitis.
Safety and herb-drug interactions
Herbs are a particular concern in MPA. Certain Chinese herbal medicines contain aristolochic acid, a plant toxin linked to kidney failure and urinary tract cancer.[6] Herbs and supplements are also a recognized cause of liver injury.[13]
Herbs can interact with the medicines used for MPA. Reviews describe interactions with immune-suppressing drugs such as ciclosporin and tacrolimus, and bleeding with warfarin.[11, 14, 15] Any herb should be reviewed by your rheumatologist or kidney specialist, come from a tested source, and be prescribed individually. Tell us about pregnancy, breastfeeding, and liver or kidney disease.
Translating traditional medicine into modern biological language
This section is interpretation, not equivalence. Chinese medicine would describe a vasculitis with fever, rash and bleeding as heat in the blood and blood stasis, and Ayurveda as aggravated Pitta with blood involvement. Biomedical researchers describe ANCA-driven neutrophil activation, complement activation and inflammation of small vessel walls.[3]
These descriptions are not equivalent, and no study has shown that a traditional pattern matches the biology of MPA or that herbs act on it.
How this care fits with your medical care
MPA needs specialist treatment, often started in a hospital. For a condition like this, we ask that you are under a physician's care for it and that your treating team knows you are receiving complementary care. Our role is supportive. We do not diagnose or manage MPA, order or interpret its tests, or prescribe or change prescription drugs.
Do not stop or change prescribed medicines, including glucocorticoids, which should not be stopped suddenly. Please bring your diagnosis, recent kidney and ANCA test results, a full list of medicines and supplements, and the names of your rheumatologist and kidney specialist.
When to seek urgent medical care
MPA can damage the kidneys and lungs quickly.[1, 3]
- Coughing up blood, or new shortness of breath
- Blood in the urine, much less urine than usual, or new swelling of the legs or face
- Fever, especially while taking immune-suppressing medicine
- Sudden weakness, numbness or foot or wrist drop
- Chest pain, severe abdominal pain, or a new spreading rash or skin ulcers
- Sudden vision changes or severe headache
If you have any of these, call 911 or go to the nearest emergency department.
Frequently asked questions
What is microscopic polyangiitis?
Microscopic polyangiitis, or MPA, is a rare autoimmune disease that inflames small blood vessels. It most often damages the kidneys and lungs and can also affect the skin and nerves. It is one of the ANCA-associated vasculitides and needs prompt treatment by specialists, usually with immune-suppressing medicines.
Can acupuncture help people with microscopic polyangiitis?
No studies have tested acupuncture in MPA, so it cannot be said to treat the disease. Research in other settings suggests acupuncture or acupressure may help symptoms such as sleep problems and fatigue, although the evidence is of low quality. We offer it only as supportive care alongside your specialists’ treatment.
Is Ayurvedic or herbal medicine safe with microscopic polyangiitis?
No studies have tested either in MPA, and herbs carry real risks. Some herbal products can harm the kidneys or liver, and herbs can interact with immune-suppressing drugs. Anything you consider should be reviewed by your rheumatologist or kidney specialist first and come from a tested source.
Can I stop or reduce my immune-suppressing medicine if I use complementary care?
No. Complementary care does not replace treatment and cannot be used to reduce or stop your medicines. Changing treatment without your specialists can lead to relapse or organ damage. Steroids in particular should not be stopped suddenly.
What should I bring to the first visit?
Bring your diagnosis, recent blood and urine results, a list of all medicines and supplements, and the names of your specialists. Tell us about skin ulcers, low blood counts or kidney disease, so that care can be planned around them.
Does insurance cover acupuncture for microscopic polyangiitis?
It may. Netra Integrative Health Clinic accepts most major insurance plans that include out-of-network acupuncture benefits, for example Aetna, Blue Cross Blue Shield, Cigna and UnitedHealthcare, and offers a free benefits check. HSA and FSA cards and CareCredit are also accepted. Call (908) 402-7301 to ask about your plan.
References
- Hashmi MF, Rout P. Microscopic Polyangiitis. StatPearls [Internet]. 2024. PMID 30285379. StatPearls chapter on microscopic polyangiitis covering definition, small vessel necrotizing vasculitis, kidney and lung involvement, ANCA role and differences from granulomatosis with polyangiitis.
- Qasim A, Patel JB. ANCA-Associated Vasculitis. StatPearls [Internet]. 2024. PMID 32119259. StatPearls chapter on ANCA-associated vasculitis describing its main forms, including microscopic polyangiitis, granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
- Kronbichler A, Bajema IM, Bruchfeld A, et al. Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024;403(10427):683-698. PMID 38368016. Lancet review of ANCA-associated vasculitis covering organ involvement, immune mechanisms, shift to targeted therapy, and long-term morbidity from kidney disease and glucocorticoids.
- Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83(1):30-47. PMID 36927642. 2022 EULAR recommendations for managing ANCA-associated vasculitis, including diagnosis by biopsy and ANCA testing, induction and maintenance therapy and plasma exchange.
- Biddle K, Jade J, Wilson-Morkeh H, et al. The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. Rheumatology (Oxford). 2025;64(8):4470-4494. PMID 40499922. 2025 British Society for Rheumatology guideline with 26 recommendations on managing granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
- Wu F, Wang T. Risk assessment of upper tract urothelial carcinoma related to aristolochic acid. Cancer Epidemiol Biomarkers Prev. 2013;22(5):812-20. PMID 23462915. Meta-analysis linking aristolochic acid in some Chinese herbal medicines to urinary tract cancer and dose-dependent end-stage kidney disease.
- Kim KH, Lee MS, Kim TH, et al. Acupuncture and related interventions for symptoms of chronic kidney disease. Cochrane Database Syst Rev. 2016;2016(6):CD009440. PMID 27349639. Cochrane review of acupuncture-related treatments for symptoms of chronic kidney disease, finding very low quality evidence for acupressure on fatigue, mood and sleep in dialysis.
- Kim SA, Lee SH, Kim JH, et al. Efficacy of Acupuncture for Insomnia: A Systematic Review and Meta-Analysis. Am J Chin Med. 2021;49(5):1135-1150. PMID 34049475. Meta-analysis of 24 trials of acupuncture for insomnia, finding better sleep scores than medication after several weeks, with high heterogeneity.
- Bäumler P, Zhang W, Stübinger T, et al. Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies. BMJ Open. 2021;11(9):e045961. PMID 34489268. Systematic review of 21 prospective studies finding minor acupuncture reactions in about 9 percent of patients and serious events in about 1 per 10,000.
- Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-23. PMID 18728265. JAMA study finding detectable lead, mercury or arsenic in about one fifth of Ayurvedic medicines purchased over the internet.
- Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs. 2005;65(9):1239-82. PMID 15916450. Literature review of herb-drug interactions, including effects on ciclosporin, tacrolimus and warfarin.
- Zhang HW, Lin ZX, Xu C, et al. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev. 2014;2014(10):CD008369. PMID 25335553. Cochrane review of 22 trials of Astragalus in chronic kidney disease, with promising effects on protein in urine but low quality and inconclusive evidence.
- Navarro VJ, Khan I, Björnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363-373. PMID 27677775. Hepatology review of liver injury from herbal and dietary supplements.
- Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: A systematic review. Br J Clin Pharmacol. 2021;87(2):352-374. PMID 32478963. Systematic review of food, herb and supplement interactions with warfarin, including several herbs that raise bleeding risk.
- Milić N, Milosević N, Golocorbin Kon S, et al. Warfarin interactions with medicinal herbs. Nat Prod Commun. 2014;9(8):1211-6. PMID 25233607. Review of reported warfarin-herb interactions with bleeding case reports.
This page is for general education and is not medical advice. Acupuncture, Ayurvedic medicine and herbal medicine are complementary therapies; they do not replace diagnosis or treatment by your physician. Do not stop or change prescribed treatment without talking to your prescriber. In an emergency call 911.
























